BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29760809)

  • 1. The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study.
    Gao S; Pu N; Liu L; Li C; Xu X; Wang X; Lou W
    J Cancer; 2018; 9(9):1698-1706. PubMed ID: 29760809
    [No Abstract]   [Full Text] [Related]  

  • 2. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
    Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
    J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised nodal stage for pancreatic neuroendocrine tumors.
    Luo G; Jin K; Cheng H; Guo M; Lu Y; Wang Z; Yang C; Xu J; Gao H; Zhang S; Zhang B; Long J; Xu J; Ni Q; Liu C; Yu X
    Pancreatology; 2017; 17(4):599-604. PubMed ID: 28610828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database.
    You Y; Jang JY; Kim SC; Yoon YS; Park JS; Cho CK; Park SJ; Yang JD; Lee WJ; Hong TH; Ahn KS; Jeong CY; Lee HK; Lee SE; Roh YH; Kim HJ; Kim H; Han IW
    Cancer Res Treat; 2019 Oct; 51(4):1639-1652. PubMed ID: 30999719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
    Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
    BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Lu J; Zhao YJ; Zhou Y; He Q; Tian Y; Hao H; Qiu X; Jiang L; Zhao G; Huang CM;
    Br J Surg; 2020 Feb; 107(3):248-257. PubMed ID: 31971627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors.
    Wang H; Ding D; Qin T; Zhang H; Liu J; Zhao J; Wu CH; Javed A; Wolfgang C; Guo S; Chen Q; Zhao W; Shi W; Zhu F; Guo X; Li X; Peng F; He R; Xu S; Jin J; Wu Y; Nuer A; Edil B; Tien YW; Jin G; Zheng L; He J; Liu J; Liu Y; Wang M; Qin R;
    HPB (Oxford); 2022 May; 24(5):681-690. PubMed ID: 34836754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
    Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
    Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms.
    Zhang Y; Shang L; Zhang PP; Chen LH; Wang W; Fang C; Qiu M; Feng XY; Zhou L; Zhang M; Tan HY; Qiu XD; Wang H; Lin R; Zhang Q; Zeng YJ; Jin KZ; Yu XJ; Shen L; Chen MH; Li J; Li LP; Chen J
    Cancer Med; 2019 Sep; 8(11):5000-5011. PubMed ID: 31293053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.
    Yang M; Zeng L; Zhang Y; Wang WG; Wang L; Ke NW; Liu XB; Tian BL
    Medicine (Baltimore); 2015 Mar; 94(12):e660. PubMed ID: 25816036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis.
    Pu N; Li J; Xu Y; Lee W; Fang Y; Han X; Zhao G; Zhang L; Nuerxiati A; Yin H; Wu W; Lou W
    Cancer Manag Res; 2018; 10():227-238. PubMed ID: 29440932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?
    Yang M; Ke NW; Zhang Y; Tan CL; Tian BL; Liu XB; Huang W; Nunes Q; Sutton R
    Oncotarget; 2017 Oct; 8(47):82784-82795. PubMed ID: 29137302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
    Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
    Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consideration of Age Is Necessary for Increasing the Accuracy of the AJCC TNM Staging System of Pancreatic Neuroendocrine Tumors.
    Wang Z; Jiang W; Zheng L; Yan J; Dai J; Huang C; Zhang Q; Yin Z; Gong X; Zhang Y
    Front Oncol; 2019; 9():906. PubMed ID: 31608226
    [No Abstract]   [Full Text] [Related]  

  • 16. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
    Li X; Gou S; Liu Z; Ye Z; Wang C
    Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems.
    Chagpar R; Chiang YJ; Xing Y; Cormier JN; Feig BW; Rashid A; Chang GJ; You YN
    Ann Surg Oncol; 2013 Apr; 20(4):1170-8. PubMed ID: 23212760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.
    Kim BS; Park YS; Yook JH; Kim BS
    Medicine (Baltimore); 2016 Jul; 95(30):e3977. PubMed ID: 27472674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.
    Liu TC; Hamilton N; Hawkins W; Gao F; Cao D
    Am J Surg Pathol; 2013 Jun; 37(6):853-9. PubMed ID: 23598967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.